Literature DB >> 638264

[Current aspects on evaluation of assays of factor-VIII activity, factor-VIII associated protein and factor-VIII neutralizing antibody (author's transl)].

G Hintz.   

Abstract

In evaluating factor-VIII activity it should be noted that regarding the remaining activity of deficient plasma a linear reference curve is achieved. In the standard population factor-VIII activity and factor-VIII associated protein are distributed approximately lognormally. Due to this distribution certain results have been gained for the optimal choice of localisation and dispersion measures. It is assumed that the proportions of neutralized factor-VIII activity in plasma are distributed according to Poisson. The applicability of the Poisson distribution was also proved for the free factor-VIII activity portion. Due to the Poisson distribution the antibody unit is clearly defined, thus eliminating a further discussion on the establishment of an arbitrary standardized antibody unit.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 638264     DOI: 10.1007/bf00996836

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  26 in total

1.  A one-stage factor VIII (antihaemophilic globulin) assay and its use on venous and capillary plasma.

Authors:  R M HARDISTY; J C MACPHERSON
Journal:  Thromb Diath Haemorrh       Date:  1962-05-15

2.  Assay of antihemophilic A, B and C factors by one-stage cephalin systems.

Authors:  O EGEBERG
Journal:  Scand J Clin Lab Invest       Date:  1961       Impact factor: 1.713

3.  Assay of the immune inhibitor in classic haemophilia: application of virus-antibody reaction kinetics.

Authors:  J G Pool; R G Miller
Journal:  Br J Haematol       Date:  1972-05       Impact factor: 6.998

4.  Factor VIII international units and reference materials.

Authors:  D R Bangham; M Brozović
Journal:  Thromb Diath Haemorrh       Date:  1974-03-15

5.  The treatment of patients who have factor-VIII antibodies.

Authors:  C R Rizza; R Biggs
Journal:  Br J Haematol       Date:  1973-01       Impact factor: 6.998

6.  The absorption of human factor VIII neutralizing antibody by factor VIII.

Authors:  R Biggs
Journal:  Br J Haematol       Date:  1974-02       Impact factor: 6.998

7.  Platelet counts, fibrinogen concentrations, and factor V and factor VIII levels in healthy infants according to gestational age.

Authors:  E J Sell; J J Corrigan
Journal:  J Pediatr       Date:  1973-06       Impact factor: 4.406

8.  The mode of action of antibodies which destroy factor VIII. II. Antibodies which give complex concentration graphs.

Authors:  R Biggs; D E Austen; K W Denson; R Borrett; C R Rizza
Journal:  Br J Haematol       Date:  1972-08       Impact factor: 6.998

9.  The immunologic character of acquired inhibitors of antihemophilic globulin (factor 8) and the kinetics of their interaction with factor 8.

Authors:  S S Shapiro
Journal:  J Clin Invest       Date:  1967-02       Impact factor: 14.808

10.  Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor.

Authors:  T S Zimmerman; O D Ratnoff; A E Powell
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

View more
  1 in total

1.  [Different proportions of factor VIII and factor VIII inhibitors in their antigen-antibody complexes].

Authors:  G Hintz; R Schwerdtfeger
Journal:  Blut       Date:  1982-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.